Literature DB >> 26060752

Indoor Radon Levels in Selected Houses in Isfahan, Central Iran.

Khadijeh Rezaee Ebrahim Saraee1, Mohammad Reza Abdi2, Fahime Mokh-Tari2, Sayed Ahmad Hosseini1, Mahyar Assadolahzade1.   

Abstract

Entities:  

Year:  2014        PMID: 26060752      PMCID: PMC4450696     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor in Chief

The highest concentration of radon (222Rn) and thoron (220Rn) in indoor environment is a major health hazard for man (1) as a result many researchers (2–4) are interested to estimate indoor radon concentration in many countries. In this study, a survey of radon and its daughters has been done to provide data on the hourly, daily and seasonal average indoor radon in Isfahan city dwellings and to estimate the effective dose to the general public. The overall average radon concentration in the surveyed area was 73.32 Bqm-3. All of the season was having a concentration of radon less than the action level (200Bqm-3) as recommended by the International Commission on Radiation Protection (ICRP) (5) and the activity level of 400 Bqm-3 given by the Turkish Atomic Energy Commission. The annual effective dose (ERn, mSv) due to the indoor radon and its progeny was calculated as E = C 8762.5 hy-1.O.D.10-6 (6), where CR is the indoor radon concentration (Bqm-3), F the equilibrium equivalent concentration factor which is 0.4 for inhabitants, O the indoor occupancy factor which is 0.8 showing that 80% of time is spent indoors and D the dose conversion factor which equal 9 nSv h-1 per Bqm-3(4). The radon content of air in the lungs has been calculated by assuming the air volume in the lungs to be 3.2 × 10-3 m3 for the ‘Reference Man’ and assuming further that the short-lived decay products will stay in the lungs, the dose rate due to alpha radiation was determined as . The effective dose equivalent rate was calculated by taking a quality factor of 20 for alpha-radiation and applying a weighting factor of 0.12 and 0.88 for the lungs other tissues, respectively, by . Equilibrium-equivalent radon concentration (EECRn) using the following equation was used to more express the indoor radon concentration, EECRn=FCR, where F is the equilibrium factor (= 0.45) and CR is the measured indoor radon activity. The equivalent dose received by bronchial pulmonary regions of human lungs has been calculated using a conversion factor 1.0 × 10-5 mSv/Bq h m3 (7). An average value of the equilibrium-equivalent radon concentration (EECRn) and the annual effective dose were calculated for each season and hours. All the results were listed in Table 1 and it shows also a variation of dose relationship from indoor radon measurements from dwellings in Isfahan area. Radon has been classified as a known human carcinogen and after cigarette smoking is a second reason which cause of lung cancer (8). The number of lung cancer deaths which may be attributed to the indoor radon exposure, were determined by , where Nr,a is the number of deaths due to indoor radon expo- sure at age a, ERRr,a is the excess relative risk for age a and radon exposure r, Na is the total number of lung cancer deaths at age a. In this study, the excess relative risk function uses of BEIR VI age concentration model (9) which at low dose rates the excess relative risk of attaining age a is , where β is the exposure-response function ranging from 6.0 × 10-3 for ages less than or equal to 55y and 5.4 × 10-4 for ages greater than 75y. The value of the β in this research was considered to be 6.0 × 10-3. The values of w5-14, w15 - 24 and, w25+ are the cumulative exposure incurred 5-14 y, 1524 y and at least 25 y before the attained age, respectively. Fifty seven lung cancer deaths were reported in the year 2012 in Isfahan city.
Table 1:

Variation of dose relationship from indoor radon measurements for dwellings in Isfahan

6AM12AM6PM12PM
D˙lung(nGyh1)
Spring3.593.723.724.17
Summer0.931.121.121.33
Autumn3.093.133.133.4
Winter4.033.923.924.25
H˙eff(nSvh1)
Spring16.1516.7516.7518.76
Summer4.25.055.056.02
Autumn13.9114.0914.0915.31
Winter18.1417.6317.6319.16
EECRn
Spring40.3741.8841.8846.89
Summer10.5112.6312.6315.04
Autumn34.7835.2435.2438.29
Winter45.3544.0844.0847.9
Variation of dose relationship from indoor radon measurements for dwellings in Isfahan Using this reported value of lung cancer death and 73.32 Bqm-3 (which is 0.45 WLM) as the geometric mean value of indoor radon concentration in the whole Isfahan city, the number of lung cancer deaths may be attributed to indoor radon exposure at age 60 yr was estimated to be about 4. Then according to this model, about 8% of lung cancer deaths in the Isfahan city are related to the indoor radon exposure.
  6 in total

1.  Indoor radon concentration in geothermal areas of central Italy.

Authors:  R Ciolini; D Mazed
Journal:  J Environ Radioact       Date:  2010-05-21       Impact factor: 2.674

2.  The effects of geology and the impact of seasonal correction factors on indoor radon levels: a case study approach.

Authors:  Gavin K Gillmore; Paul S Phillips; Antony R Denman
Journal:  J Environ Radioact       Date:  2005-06-27       Impact factor: 2.674

3.  Indoor radon survey in dwellings of the Kars province, Turkey.

Authors:  N Celik; A Poffijn; U Cevik; L Schepens
Journal:  Radiat Prot Dosimetry       Date:  2007-10-18       Impact factor: 0.972

4.  Indoor radon measurements in the granodiorite area of Bergama (Pergamon)-Kozak, Turkey.

Authors:  Ozlem Karadeniz; Günseli Yaprak; Cüneyt Akal; Ipek Emen
Journal:  Radiat Prot Dosimetry       Date:  2011-06-01       Impact factor: 0.972

5.  Inhalation dose assessment of indoor radon progeny using biokinetic and dosimetric modeling and its application to Jordanian population.

Authors:  J Al-Jundi; W B Li; M Abusini; J Tschiersch; C Hoeschen; U Oeh
Journal:  J Environ Radioact       Date:  2011-04-08       Impact factor: 2.674

6.  Protection against radon-222 at home and at work. A report of a task group of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1993
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.